FDA approves first generic of ProAir HFA inhalation aerosol
The generic of ProAir HFA (albuterol sulfate) inhalation aerosol has been approved by the FDA to advance patient access to lower-cost medicines.
List view / Grid view
The generic of ProAir HFA (albuterol sulfate) inhalation aerosol has been approved by the FDA to advance patient access to lower-cost medicines.
This article highlights the 10 most popular news stories published by European Pharmaceutical Review in 2019.
23 November 2015 | By Victoria White
Perrigo will pay AstraZeneca $380 million upon completion of the transaction to acquire the rights to sell Entocort capsules...
14 September 2015 | By Victoria White
Under the terms of the offer, Perrigo shareholders will receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share...
11 September 2015 | By Victoria White
Allergan has said that its partner, Perrigo, will begin shipments of the products to its retail and wholesale customers in the US in time for the 2016 cough and cold season...
28 August 2015 | By Victoria White
Mylan's proposed acquisition of Perrigo received the approval of two-thirds of the votes cast by Mylan shareholders at an extraordinary general meeting...
25 August 2015 | By CI Precision
Perrigo UK recently installed three SP-4C tablet and capsule sample weight checkers from specialist weighing equipment manufacturer CI Precision...
17 August 2015 | By Victoria White
The ISS has recommended that Mylan shareholders vote "against" the unsolicited offer to acquire all of the outstanding shares of Perrigo...